Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2017

View Archived Issues

Endocyte to collaborate with Seattle Children's Research Institute in CAR T-cell setting

TiGenix reports topline results from phase I/II trial of AlloCSC-01 in acute myocardial infarction

Zafgen discloses novel MetAP 2 inhibitors

First European approval of new breast cancer indication for Decapeptyl

Galera Labs describes new manganese complex prodrugs

Shanghai Institute Materia Medica divulges pyridazinone compounds for HBV infection

Astellas patents alpha-7 nicotinic receptor positive allosteric modulators

Heptares and Daiichi Sankyo collaborate in pain

GlaxoSmithKline presents new antibacterials

Pituitary homeobox 2, a biomarker of progression in breast cancer

Almac Diagnostics selected by EORTC for molecular profiling of cancer patient samples

Activity seen in phase II study of tipifarnib in HRAS-mutant head and neck cancer

Chinese phase I trial investigates anti-CD22 CAR-T therapy in CD19-refractory or resistant lymphoma

New phase II trial in China explores use of anlotinib for small cell lung cancer

Duchesnay acquires U.S. and Canadian rights to market and distribute Osphena

Microbion initiates phase Ib/IIa study of MBN-101 for moderate to severe diabetic foot infection

TFE3 and SOX11 found as diagnostic markers for solid pseudopapillary neoplasms

AbbVie initiates phase I study of immunotherapy ABBV-927 in advanced solid tumors

Urinary tetranor-PGDM can indicate food allergy reactions in children

Intrexon creates wholly owned subsidiary Precigen

EHD2, a new prognostic marker in papillary thyroid carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...